#FDA gives emergency clearance to Eli Lilly’s experimental COVID-19 drug

#FDA gives emergency clearance to Eli Lilly’s experimental COVID-19 drug

“#FDA gives emergency clearance to Eli Lilly’s experimental COVID-19 drug” The Food and Drug Administration on Monday issued an emergency clearance to Eli Lilly’s experimental COVID-19 antibody treatment. The drug, praised by President Trump, was proven effective in clinical trials at reducing the need for hospitalizations in coronavirus patients at high risk of disease progression,…

Read More
#FDA panel urges rejection of experimental Alzheimer’s drug

#FDA panel urges rejection of experimental Alzheimer’s drug

“#FDA panel urges rejection of experimental Alzheimer’s drug” WASHINGTON — Government health advisers sharply criticized a closely watched Alzheimer’s drug on Friday, concluding there wasn’t enough evidence that the experimental drug slowed the brain-destroying disease. The panel of outside experts for the Food and Drug Administration agreed that a pivotal study in patients failed to…

Read More
#Moderna’s COVID-19 vaccine could be ready by December

#Moderna’s COVID-19 vaccine could be ready by December

“#Moderna’s COVID-19 vaccine could be ready by December” The feds could clear Moderna’s experimental coronavirus vaccine for emergency use in December if the company’s clinical research goes according to plan, CEO Stéphane Bancel reportedly said. That timeline depends on the Massachusetts-based biotech firm getting positive results next month from its late-stage clinical trial of the…

Read More
#Diabetes drug Metformin recalled due to high level of cancer agent

#Diabetes drug Metformin recalled due to high level of cancer agent

“#Diabetes drug Metformin recalled due to high level of cancer agent” The diabetes drug Metformin hydrochloride has been recalled because it contains excess levels of a cancer-causing agent, the U.S. Food and Drug Administration announced this week. The drug’s manufacturer, Marksans Pharma Limited, has expanded a recall initially announced in June to now include an…

Read More